Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Balance Labs (BLNC) EBT (2016 - 2025)

Balance Labs filings provide 10 years of EBT readings, the most recent being -$12.8 million for Q4 2025.

  • On a quarterly basis, EBT changed N/A to -$12.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$13.3 million, a N/A change, with the full-year FY2025 number at -$13.3 million, down 2548.07% from a year prior.
  • EBT hit -$12.8 million in Q4 2025 for Balance Labs, down from -$271991.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $255883.0 in Q4 2021 to a low of -$12.8 million in Q4 2025.
  • Median EBT over the past 4 years was -$92595.0 (2023), compared with a mean of -$924569.3.
  • Biggest five-year swings in EBT: surged 130.08% in 2021 and later crashed 518.97% in 2023.
  • Balance Labs' EBT stood at $255883.0 in 2021, then plummeted by 130.25% to -$77411.0 in 2022, then dropped by 18.83% to -$91985.0 in 2023, then tumbled by 13780.7% to -$12.8 million in 2025.
  • The last three reported values for EBT were -$12.8 million (Q4 2025), -$271991.0 (Q3 2025), and -$135779.0 (Q2 2025) per Business Quant data.